Search Results - "Whitley, C. B."

Refine Results
  1. 1

    Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome by Tolar, J, Grewal, S S, Bjoraker, K J, Whitley, C B, Shapiro, E G, Charnas, L, Orchard, P J

    Published in Bone marrow transplantation (Basingstoke) (01-03-2008)
    “…Hurler syndrome (mucopolysaccharidosis type I, MPS IH) is characterized by a deficiency of α- L -iduronidase resulting in progressive multiorgan dysfunction…”
    Get full text
    Journal Article
  2. 2

    Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation by Polgreen, L E, Tolar, J, Plog, M, Himes, J H, Orchard, P J, Whitley, C B, Miller, B S, Petryk, A

    Published in Bone marrow transplantation (Basingstoke) (01-06-2008)
    “…Short stature is characteristic of Hurler syndrome, or mucopolysaccharidosis type IH (MPS IH). Hematopoietic stem cell transplantation (HSCT) is used to treat…”
    Get full text
    Journal Article
  3. 3

    Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I by Wolf, D A, Lenander, A W, Nan, Z, Braunlin, E A, Podetz-Pedersen, K M, Whitley, C B, Gupta, P, Low, W C, McIvor, R S

    Published in Bone marrow transplantation (Basingstoke) (01-09-2012)
    “…Mucopolysaccharidosis type I (MPS I) is an autosomal recessive inherited disease caused by deficiency of the glycosidase α- L -iduronidase (IDUA). Deficiency…”
    Get full text
    Journal Article
  4. 4

    SAAMP 2.0: An algorithm to predict genotype‐phenotype correlation of lysosomal storage diseases by Ou, L., Przybilla, M.J., Whitley, C.B.

    Published in Clinical genetics (01-05-2018)
    “…Lysosomal storage diseases (LSDs) are a group of genetic disorders, resulting from deficiencies of lysosomal enzyme. Genotype‐phenotype correlation is…”
    Get full text
    Journal Article
  5. 5

    The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome by Eisengart, J.B., King, K.E., Shapiro, E.G., Whitley, C.B., Muenzer, J.

    Published in Molecular genetics and metabolism reports (01-03-2020)
    “…In neuronopathic Hunter syndrome, neurobehavioral symptoms are known to be serious but have been incompletely described. While families face significant stress…”
    Get full text
    Journal Article
  6. 6

    Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I by PAN, D, ARONOVICH, E, MCIVOR, R. S, WHITLEY, C. B

    Published in Gene therapy (01-11-2000)
    “…To optimize a gene transfer system for hematopoietic stem cell gene therapy of patients with mucopolysaccharidosis (MPS) type I, 10 retroviral vectors were…”
    Get full text
    Journal Article
  7. 7

    Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion by Whitley, C B, Ridnour, M D, Draper, K A, Dutton, C M, Neglia, J P

    Published in Clinical chemistry (Baltimore, Md.) (01-03-1989)
    “…This direct method for quantifying excessive urinary glycosaminoglycan excretion exploits the specific binding of 1,9-dimethylmethylene blue (DMB). The…”
    Get more information
    Journal Article
  8. 8

    Real-time quantitative polymerase chain reaction to assess gene transfer by Becker, K, Pan, D, Whitley, C B

    Published in Human gene therapy (10-10-1999)
    “…Accurate quantification of gene transfer (or gene correction) is a universal challenge in the field of gene therapy. In developing a clinical trial of…”
    Get more information
    Journal Article
  9. 9
  10. 10

    A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy by Silvestri, G, Santorelli, F M, Shanske, S, Whitley, C B, Schimmenti, L A, Smith, S A, DiMauro, S

    Published in Human mutation (1994)
    “…We report a new mutation, a C to T transition at nt 3303 of mtDNA, in seven members of a family with cardiomyopathy and myopathy: the proband and two siblings…”
    Get more information
    Journal Article
  11. 11

    Molecular genetic defect underlying α-L-iduronidase pseudodeficiency by ARONOVICH, E. .L, DAO PAN, WHITLEY, C. B

    “…Mucopolysaccharidosis type I (i.e., Hurler, Hurler-Scheie, and Scheie syndromes) and type II (i.e., Hunter syndrome) are lysosomal storage disorders resulting…”
    Get full text
    Journal Article
  12. 12

    Genotype-Phenotype Correspondence in Sanfilippo Syndrome Type B by Zhao, Hong G., Aronovich, Elena L., Whitley, Chester B.

    Published in American journal of human genetics (01-01-1998)
    “…Sanfilippo syndrome type B, or mucopolysaccharidosis type IIIB, results from defects in the gene for α-N-acetylglucosaminidase (NAGLU); only a few mutations…”
    Get full text
    Journal Article
  13. 13

    NAGLU Mutations Underlying Sanfilippo Syndrome Type B by Schmidtchen, Artur, Greenberg, David, Zhao, Hong G., Li, Hong Hua, Huang, Yan, Tieu, Phuong, Zhao, Hui-Zhi, Cheng, Samson, Zhao, Zhaoyang, Whitley, Chester B., Di Natale, Paola, Neufeld, Elizabeth F.

    Published in American journal of human genetics (01-01-1998)
    “…Sanfilippo syndrome type B (mucopolysaccharidosis III B) is a rare autosomal recessive disease caused by deficiency of α-N-acetylglucosaminidase, one of the…”
    Get full text
    Journal Article
  14. 14

    Busulfan Disposition in Children by Grochow, Louise B., Krivit, William, Whitley, Chester B., Blazar, Bruce

    Published in Blood (15-04-1990)
    “…Children receive busulfan orally as part of myeloablative therapy before bone marrow transplantation for malignant and nonmalignant conditions. Children have…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Combined ultrafiltration-transduction in a hollow-fiber bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II by Pan, D, Shankar, R, Stroncek, D F, Whitley, C B

    Published in Human gene therapy (20-11-1999)
    “…The process of growing and transducing large quantities of human primary peripheral blood lymphocytes (PBLs) with high gene transfer efficiency continues to be…”
    Get more information
    Journal Article
  17. 17

    Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome by Stroncek, David F., Hubel, Allison, Shankar, Raji A., Burger, Scott R., Pan, Dao, McCullough, Jeffrey, Whitley, Chester B.

    Published in Transfusion (Philadelphia, Pa.) (01-04-1999)
    “…BACKGROUND: Gene therapy using autologous peripheral blood lymphocytes (PBLs) has been used to produce adenosine deaminase with which to treat patients with…”
    Get full text
    Journal Article
  18. 18

    Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene by Hartung, S D, Reddy, R G, Whitley, C B, McIvor, R S

    Published in Human gene therapy (01-09-1999)
    “…Mucopolysaccharidosis type I (MPS I), a deficiency in the lysosomal enzyme alpha-L-iduronidase (IDUA), is characterized by skeletal abnormalities,…”
    Get more information
    Journal Article
  19. 19

    Retroviral transduction of peripheral blood leukocytes in a hollow- fiber bioreactor by Shankar, Raji, Whitley, Chester B., Pan, Dao, Burger, Scott, McCullough, Jeffrey, Stroncek, David

    Published in Transfusion (Philadelphia, Pa.) (01-07-1997)
    “…BACKGROUND: Peripheral blood white cells (leukocytes) (PBLs) have been used as effective targets for genetic manipulation by transduction with retroviruses in…”
    Get full text
    Journal Article
  20. 20

    Pathology of the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation by Resnick, J M, Krivit, W, Snover, D C, Kersey, J H, Ramsay, N K, Blazar, B R, Whitley, C B

    Published in Bone marrow transplantation (Basingstoke) (01-09-1992)
    “…Serial liver biopsies were obtained in 20 patients undergoing bone marrow transplantation (BMT) for mucopolysaccharidosis (MPS). The 13 patients with MPS I,…”
    Get more information
    Journal Article